Works matching IS 15414035 AND DT 2003 AND VI 3
1
- PharmaGenomics, 2003, v. 3, p. 14
- Article
2
- PharmaGenomics, 2003, v. 3, p. 13
- Article
3
- PharmaGenomics, 2003, v. 3, p. 15
- Article
4
- PharmaGenomics, 2003, v. 3, p. 12
- Article
5
- PharmaGenomics, 2003, v. 3, p. 38
- Article
6
- PharmaGenomics, 2003, v. 3, p. 37
- Article
7
- PharmaGenomics, 2003, v. 3, p. 36
- Article
8
- PharmaGenomics, 2003, v. 3, p. 35
- Article
9
- PharmaGenomics, 2003, v. 3, p. 34
- Article
10
- PharmaGenomics, 2003, v. 3, p. 33
- Article
11
- PharmaGenomics, 2003, v. 3, p. 16
- Article
12
- PharmaGenomics, 2003, v. 3, p. 32
- Article
13
- PharmaGenomics, 2003, v. 3, p. 31
- Article
14
- PharmaGenomics, 2003, v. 3, p. 30
- Article
15
- PharmaGenomics, 2003, v. 3, p. 28
- Article
16
- PharmaGenomics, 2003, v. 3, p. 27
- Article
17
- PharmaGenomics, 2003, v. 3, p. 26
- Article
18
- PharmaGenomics, 2003, v. 3, p. 24
- Article
19
- PharmaGenomics, 2003, v. 3, p. 23
- Article
20
- PharmaGenomics, 2003, v. 3, p. 22
- Article
21
- PharmaGenomics, 2003, v. 3, p. 20
- Article
22
- PharmaGenomics, 2003, v. 3, p. 19
- Article
23
- PharmaGenomics, 2003, v. 3, p. 18
- Article
24
- PharmaGenomics, 2003, v. 3, p. 10
- Article
25
- PharmaGenomics, 2003, v. 3, p. 8
- Article
26
- PharmaGenomics, 2003, v. 3, p. 7
- Article
27
- PharmaGenomics, 2003, v. 3, p. 6
- Article
28
- PharmaGenomics, 2003, v. 3, n. 9, p. 66
- Article
29
- PharmaGenomics, 2003, v. 3, n. 9, p. 65
- Article
30
- PharmaGenomics, 2003, v. 3, n. 9, p. 56
- Kenney, Beverly;
- Shockor, John P.
- Article
31
- PharmaGenomics, 2003, v. 3, n. 9, p. 42
- Wells, David A.;
- Weil, David A.
- Article
32
- PharmaGenomics, 2003, v. 3, n. 9, p. 28
- Meza, Jose E.;
- Donghui Yi;
- Miller, Christine A.;
- Perkins, Patrick D.
- Article
33
- PharmaGenomics, 2003, v. 3, n. 9, p. 22
- Article
34
- PharmaGenomics, 2003, v. 3, n. 9, p. 18
- Article
35
- PharmaGenomics, 2003, v. 3, n. 9, p. 16
- Article
36
- PharmaGenomics, 2003, v. 3, n. 9, p. 16
- Article
37
- PharmaGenomics, 2003, v. 3, n. 9, p. 10
- Article
38
- PharmaGenomics, 2003, v. 3, n. 9, p. 10
- Article
39
- PharmaGenomics, 2003, v. 3, n. 8, p. 74
- Article
40
- PharmaGenomics, 2003, v. 3, n. 8, p. 70
- Article
41
- PharmaGenomics, 2003, v. 3, n. 8, p. 64
- Henry, R.D.;
- Preister, G.;
- Thomas, R.J.
- Article
42
- PharmaGenomics, 2003, v. 3, n. 8, p. 56
- Article
43
- PharmaGenomics, 2003, v. 3, n. 8, p. 46
- Kolodsick, Kevin J.;
- Rossi, David T.;
- Kingsmill, Carol A.
- Article
44
- PharmaGenomics, 2003, v. 3, n. 8, p. 32
- Article
45
- PharmaGenomics, 2003, v. 3, n. 8, p. 26
- Article
46
- PharmaGenomics, 2003, v. 3, n. 8, p. 24
- Sinskey, Anthony J.;
- Finkelstein, Stan N.;
- Cooper, Scott M.
- Article
47
- PharmaGenomics, 2003, v. 3, n. 8, p. 16
- Nikolsky, Yuri;
- Gotschall, Mary
- Article
48
- PharmaGenomics, 2003, v. 3, n. 8, p. 14
- Article
49
- PharmaGenomics, 2003, v. 3, n. 8, p. 10
- Article
50
- PharmaGenomics, 2003, v. 3, n. 8, p. 10
- Article